Articles From: UPDATE: 3 stocks with almost no redeeming qualities to UPDATE: What are people buying with their iPhones? Big Macs and organic food


2014/12/22
By Jeff Reeves, MarketWatch These stinkers will almost surely be lower a year from now The financial media are rife with "best of" lists to end the year --
Sign-up for UPDATE: 3 stocks with almost no redeeming qualities investment picks
By MarketWatch, MarketWatch Energy plays fall again NEW YORK (MarketWatch) -- These stocks are making moves Monday: Gilead Sciences Inc.(GILD) is slumping and AbbVie Inc.(ABBV) is gaining after Express Scripts Holding Co.(ESRX), the largest manager of U.S. prescription-drug benefits, decided an AbbVie drug will be its exclusive option for treating the most common form of hepatitis C.
Sign-up for UPDATE: AbbVie, American Apparel gain; Gilead sinks investment picks
2014/12/22
By Brett Arends, MarketWatch Is a gift to a foreign official really the same as a bribe?
Sign-up for UPDATE: Avon pays the price under America's absurd bribery law investment picks
2014/12/22
By William Watts and Joseph Adinolfi, MarketWatch Not your garden-variety black swan U.S. stocks climbed a wall of worry in 2014 underpinned by a host of nettlesome concerns at home and abroad.
Sign-up for UPDATE: Call it a gray swan: 10 risks that could upend the market in 2015 investment picks
2014/12/22
By Jennifer Booton, MarketWatch Eyes on BlackBerry to diversify beyond branded devices NEW YORK (MarketWatch) -- Is BlackBerry's once-loved Classic phone enough to lure you back to the battered device maker?
Sign-up for UPDATE: Classic smartphone not the blockbuster BlackBerry needs investment picks
2014/12/22
By Mark Hulbert, MarketWatch Popular market-timing strategy seems to have lost its edge CHAPEL HILL, N.C. (MarketWatch) -- Profiting from the so-called January Effect used to be as close to a sure thing as the stock market ever provided.
Sign-up for UPDATE: Don't let the small-cap 'January Effect' chill your stock portfolio investment picks
2014/12/22
By Carla Mozee, MarketWatch Alstom pays record bribery-related penalty in the U.S. LONDON (MarketWatch) -- European stocks rose Monday, staking out gains during the holiday-shortened week, though the energy group lost steam as oil prices swung lower.
Sign-up for UPDATE: European oil shares pull back, but benchmark logs gain investment picks
Drugmaker Gilead Sciences Inc. (GILD) recorded its largest single-session fall since its January 1992 initial public offering Monday after a pharmacy benefit manager dropped the company's Hepatitis C drug in favor of a rival's product.
Sign-up for UPDATE: Gilead sees largest one-day drop since IPO investment picks
By MarketWatch, MarketWatch Steelcase to post earnings after Monday's close NEW YORK (MarketWatch) -- These are the stocks that could grab the spotlight Monday, as a holiday-shortened trading week begins: Gilead Sciences Inc.(GILD) is slumping and AbbVie Inc.(ABBV) is gaining after Express Scripts Holding Co.(ESRX) , the largest manager of U.S. prescription-drug benefits, decided an AbbVie drug will be its exclusive option for treating the most common form of hepatitis C.
Sign-up for UPDATE: Gilead, AbbVie, Denbury in focus investment picks
By Victor Reklaitis, MarketWatch 'Simply no reason to buy Russia,' one strategist says NEW YORK (MarketWatch) -- Russia's stocks performed badly, or uzhasno as Vladimir Putin might put it, while India's stocks registered a terrific 2014 thanks to "Modi mania" -- and each country's equity market easily could stay on its current track in 2015.
Sign-up for UPDATE: Here are the worst countries for investors in 2014 -- and maybe 2015, too investment picks
2014/12/22
Of the 84 components of the S&P 500 Financials sector, 10 are down this year.
Sign-up for UPDATE: How to find 'winners' among the worst -2- investment picks
2014/12/22
By Philip van Doorn, MarketWatch Your research may tell you that some companies have been unfairly punished As we start the holiday week, one way to identify possible stock market presents for 2015 is to look at this year's worst performers.
Sign-up for UPDATE: How to find 'winners' among the worst S&P 500 stocks investment picks
2014/12/22
By Brett Arends, MarketWatch Is a gift to a foreign official really the same as a bribe?
Sign-up for UPDATE: Is your company being 'corrupt'? investment picks
2014/12/22
Then you have the Knicks.
Sign-up for UPDATE: Major league sports' biggest Santas -2- investment picks
2014/12/22
By Jason Notte, MarketWatch Would you pay $676 for your family to see the Knicks?
Sign-up for UPDATE: Major league sports' biggest Santas and Scrooges investment picks
2014/12/22
By Anora Mahmudova and Sara Sjolin, MarketWatch Dow industrials leads Wall Street gains NEW YORK (MarketWatch) -- U.S. stocks continued to build on last week's big Fed-inspired rally, putting the benchmark S&P 500 on track for a record close.
Sign-up for UPDATE: Modest gains for U.S. stock push S&P toward fresh record investment picks
2014/12/22
By MarketWatch, MarketWatch Steelcase to post earnings after Monday's close NEW YORK (MarketWatch) -- These are the stocks that could grab the spotlight Monday, as a holiday-shortened trading week begins: Nabors Industries Ltd.(NBR), Denbury Resources Inc.(DNR) and other energy names will see if they can recover further from their slide in the last few months that's been sparked by crude oil's crash.
Sign-up for UPDATE: Nabors, Denbury, other energy stocks in focus investment picks
2014/12/22
By Anora Mahmudova and Sara Sjolin, MarketWatch Technology, telecoms stocks lead rally NEW YORK (MarketWatch) -- The S&P 500 and Dow Jones Industrial Average ended Monday at new records, fueled by continued hopes that the Federal Reserve won't be in a rush to raise interest rates.
Sign-up for UPDATE: S&P 500, Dow industrials close at records investment picks
2014/12/22
By Liz Moyer Some ultra-rich hire consultants to secure homes, vet staff, protect information It's a dangerous world, no matter how much money you have.
Sign-up for UPDATE: Security risks get wealthy families' attention investment picks
2014/12/22
By Catey Hill, MarketWatch As the holidays near, stores are trying to squeeze every penny from our wallets -- but many shoppers aren't having it.
Sign-up for UPDATE: Shopping today? It pays to compare prices on these things investment picks
By Wallace Witkowski, MarketWatch Chesapeake narrows regular session loss on buyback plan SAN FRANCISCO (MarketWatch) -- Steelcase Inc. shares declined in the extended session Monday after the office-furnishings company's revenue for the third quarter fell short of Wall Street estimates.
Sign-up for UPDATE: Steelcase shares slide as revenue comes in light investment picks
2014/12/22
By Shawn Langlois, MarketWatch Critical intelligence before the U.S. market opens "Yeah, there's definitely a lot of stingrays out there today," my 11-year-old daughter, ever the alarmist, randomly warned me on Sunday afternoon as we dipped our toes into the water.
Sign-up for UPDATE: Stock market may wish investors a wary Christmas investment picks
Tesco Corp.
Sign-up for UPDATE: Tesco Corp. warns of profit, sales miss investment picks
2014/12/22
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks popped higher Monday, with energy shares among the advancers pushing up the benchmark FTSE 100 at the start of the holiday-shortened week.
Sign-up for UPDATE: U.K. stocks bounce up at start of holiday-shortened week investment picks
2014/12/22
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks rose Monday, though energy shares on the resource-heavy FTSE 100 benchmark pared gains as oil prices began losing ground.
Sign-up for UPDATE: U.K. stocks rise at start of holiday-shortened week investment picks
2014/12/22
By Anora Mahmudova and Sara Sjolin, MarketWatch AbbVie jumps on FDA's hepatitis C drug approval NEW YORK (MarketWatch) -- After a robust snap-back rally last week, U.S. stocks struggled to keep momentum on Monday in a holiday-shortened week.
Sign-up for UPDATE: U.S. stocks edge higher in thin trade investment picks
By Anora Mahmudova and Sara Sjolin, MarketWatch AbbVie jumps on FDA's hepatitis C drug approval NEW YORK (MarketWatch) -- After a robust snap-back rally last week, U.S. stocks struggled to keep momentum on Monday in a shortened Christmas week.
Sign-up for UPDATE: U.S. stocks struggle to move higher investment picks
2014/12/22
By Anora Mahmudova and Sara Sjolin, MarketWatch AbbVie jumps on FDA's hepatitis C drug approval NEW YORK (MarketWatch) -- U.S. stock futures were slightly higher on Monday amid some year-end deal making in a shortened Christmas week.
Sign-up for UPDATE: U.S. stocks: Futures point to higher open; existing-home sales next investment picks
2014/12/22
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.S. stock futures pointed to a higher open on Monday, as a rally in oil prices lifted global markets and signaled a return to calm for the shortened Christmas week, after the turmoil of earlier in December.
Sign-up for UPDATE: U.S. stocks: Futures point to upbeat open but low-volume day as Christmas nears investment picks
By Jennifer Booton, MarketWatch Apple's shares of the mobile payments market has hit 1.7% NEW YORK (MarketWatch)-- Apple Inc. users have a love affair with organic food, but they don't mind stretching for a Big Mac sometimes, either.
Sign-up for UPDATE: What are people buying with their iPhones? Big Macs and organic food investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: 3 stocks with almost no redeeming qualities to UPDATE: What are people buying with their iPhones? Big Macs and organic food
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent